THE IMPACT OF A PHARMACIST-PROVIDED TELEPHONE MEDICATION THERAPY MANAGEMENT PROGRAM ON MEDICATION AND HEALTH-RELATED PROBLEMS, MEDICATION ADHERENCE, AND TOTAL DRUG COSTS AMONG MEDICARE BENEFICIARIES- A 6-MONTH FOLLOW-UP

Author(s)

Leticia R. Moczygemba, PharmD, PhD, Assistant Professor1, Jamie C Barner, PhD, Associate Professor2, Kenneth A Lawson, PhD, Associate Professor2, Carolyn M Brown, PhD, Associate Professor2, Evelyn Gabrillo, PharmD, Clinical Specialist3, Paul J Godley, PharmD, Director, Clinical Services4, Michael Johnsrud, PhD, Associate Director21Virginia Commonwealth University, Richmond, VA, USA; 2 University of Texas at Austin, Austin, TX, USA; 3 Scott and White Health Plan, Temple, TX, USA; 4 Scott and White Health System, Temple, TX, USA

OBJECTIVES To determine if differences existed between the intervention group [after participating in a pharmacist-provided telephone medication therapy management (PPMTM) program] and the control group in: 1) Medication/health-related problems (MHRPs); 2) Medication adherence; and 3) Total Part D drug costs. METHODS This quasi-experimental study of Part D beneficiaries from a Texas health plan used the Andersen Model as its theoretical framework. Predisposing factors were age, gender, and race; need factors were number of medications, number of chronic diseases and medication regimen complexity. The intervention and control groups were matched on number of medications and number of chronic diseases. The health behavior was PPMTM participation. Outcomes were changes in: 1) Number of MHRPs; 2) Medication adherence using medication possession ratio (MPR); and 3) Total drug costs. Multivariate regression was used for group comparisons of outcomes. RESULTS The intervention (n = 60) and control (n = 60) groups were not statistically different in predisposing or need factors except for gender (intervention = 51.7% male; control = 28.3% male; p=0.009). At baseline, 4.8 (± 2.7) MHRPs were identified in the intervention group and 9.2 (± 2.9) in the control group. At the 6-month follow-up, 2.5 (± 2.0) and 7.9 (± 3.0) MHRPs remained, respectively. Multivariate regression revealed that the intervention group had significantly more MHRPs resolved (p=0.0003) when compared to the control group, while controlling for predisposing and need factors. There were no other significant predictors of MHRP resolution, Analyses showed no significant predictors of change in MPR or total drug costs from baseline to 6-month follow-up. CONCLUSIONS A telephone MTM program was effective in resolving MHRPs among Medicare beneficiaries; however, no significant differences existed between the intervention and control groups in medication adherence and total drug costs.

Conference/Value in Health Info

2009-05, ISPOR 2009, Orlando, FL, USA

Value in Health, Vol. 12, No. 3 (May 2009)

Code

HM4

Topic

Patient-Centered Research

Topic Subcategory

Adherence, Persistence, & Compliance

Disease

Geriatrics, Pediatrics

Explore Related HEOR by Topic


Your browser is out-of-date

ISPOR recommends that you update your browser for more security, speed and the best experience on ispor.org. Update my browser now

×